Navigation Links
Cytochroma Closes $45 Million Series C Financing
Date:7/30/2008

>About Cytochroma

Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent the clinical consequences of vitamin D insufficiency and SHPT associated with CKD. The Company's vitamin D-based therapeutics are designed to safely and effectively treat patients with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat hyperphosphatemia in these same patients. For more information, please visit http://www.cytochroma.com.


'/>"/>
SOURCE Cytochroma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cytochroma Appoints R. Richard Wieland II As CFO
2. Cytochroma opens U.S. headquarters in Illinois
3. Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease
4. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
5. AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury
6. Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors
7. MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures
8. Raptor Pharmaceuticals Closes $10 Million Private Placement
9. China Pharma Holdings, Inc. Closes $10 Million Financing
10. Transdel Pharmaceuticals Closes $4 Million Financing
11. Dilon Technologies Closes First Quarter With Record Sales

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ative new study, a University of Utah scientist ar...or cause of global warming cannot be stabilized u...lds the equivalent of one new nuclear power plant ...be any substantial near-term departure from recent...n rates," says the new paper by Tim Garrett, an as...
(Date:11/23/2009)...nication, computation and more powerful ways to en...ntum states as carriers of information is an extre...own, mathematically, how to gently tease out unwan...the information intact. Their work is reported in ... highlighted with a Viewpoint in Physics ( http:...
(Date:11/23/2009)...-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI )...009astheex-dividenddateforits$200millionspecialdiv...ransactioncompletedonNovember2,2009.Thedividendwil...ntherecorddate,December1,2009.NASDAQhassettheappro...commonstockforpurposesoftheex-dividenddateonNovemb...
(Date:11/23/2009)...Call/--NeogenCorporation(Nasdaq: NEOG )announcedto...BoardofDirectorsatthecompany,srecentannualmeetingo...perienceinthefood,agriculture,andtradeindustriesan...economicsatVirginiaTechUniversity.FromJanuary2006u...negotiatorwiththerankofambassador. ,, "Sinceour...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2
... The International,Confocal Microscopy Working Gro...and students, has been formed as a means to promot...onfocal microscopy (RCM) in,patient care., The Wo...dwide.,Dermatologists, dermascopists, dermatopatho...interested in learning more about RCM should consi...
...e Therapeutics,Inc. (OTC Bulletin Board: NILT.OB),... therapies for cardiovascular disease, is pleased ...., F.A.C.C. as its Vice President of,Clinical Rese...e. Dr. Lieu has extensive,cardiovascular clinical ...y,beneficial to Nile and our CD-NP and 2NTX-99 dev...
... Strativa,Pharmaceuticals, the proprietary product...rmaceutical Companies, Inc. (NYSE: PRX ) today,an...maceuticals, Inc.,(Amex: IMM ) has chosen to disc...aleate, an investigative therapy., On February 22...itional,reports of adverse events related to abnor...
Other Biology Technology:International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy 2Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 2Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 3Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 2Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 3
(Date:11/23/2009)...ridge, Mass. November 23, 2009 Applied mathemati...y ( Hosta lancifolia ), a characteristic long leaf...ked ripples along the edges. The simple cause of t...ng from bending during differential growthwas reve...ing foam ribbons. , Haiyi Liang, a postdoctoral ...
(Date:11/23/2009)...IGN, Ill. A new study provides "incontrovertible ... on the island of Sumatra about 73,000 years ago d...from the epicenter, researchers report. , The vo... ash into the atmosphere, leaving a crater (now th...eters long and 35 kilometers wide. Ash from the ev...
(Date:11/23/2009)..., N.H. University of New Hampshire microbiologist...115 to advance understanding of the actinorhizal p...nrich nutrient-poor and contaminated soils. , T...awarded Tisa, a professor of molecular, cellular a...mbiotic relationship between the bacteria Frankia ...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Expensive Health Care 3A Undetected Unmet Mobility Needs Creating Boomer 26 Senior Health Care Costs 54289 1Expensive Health Care 3A Undetected Unmet Mobility Needs Creating Boomer 26 Senior Health Care Costs 54289 2Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 1Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 2Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 3American Nurses Association Joins the National Healthcare Career Network 54285 1American Nurses Association Joins the National Healthcare Career Network 54285 2American Nurses Association Joins the National Healthcare Career Network 54285 3
...A protein that causes coral to glow is helping res...edicine to light up brain cells that are critical ...system. This fluorescent marker protein may shed l... in various neurological diseases. The researchers...ember 20, 2006, issue of The Journal of Neuroscien...
...Mayo Clinic Cancer Center has opened a new Phase I...s against multiple myeloma, a cancer of the bone m...d of a series of molecular medicine studies in pat...cer. , “This is the beginning of a long but excit...logist and lead researcher on the multiple myeloma...
...Returning from a recent 1,000-mile expedition acro...ervation Society (WCS) biologist George Schaller r...t of rampant poaching -- may be increasing in numb... a growing conservation ethic in local communities... WCS and National Geographic, took place over a re...
Other Biology News:Researchers develop marker that identifies energy-producing centers in nerve cells 2Investigating the measles virus as a tool to kill multiple myeloma 2Investigating the measles virus as a tool to kill multiple myeloma 3Tibetan antelope slowly recovering, WCS says 2
Corning 96 Well Eia/Ria Microplate,Flat Bottom,Med Binding,Non-Sterile,W/O Lid from Sigma-Aldrich
...ss-to-seal gasket and cover slip enclosures which ...idizing and imaging thick or free floating specime...uild up to three chambers per slide. Minimize spec...ven when submerged. RNase-free, ready to use for m...
Secure-Seal hybridization chambers from Sigma-Aldrich
LC-NMR-MSn system from Bruker Daltonics
Biology Products: